Growth factor deficiency in patients with ataxia telangiectasia

Clinical and Experimental Immunology

Volumn 140, Issue 3, 2005, Pages 517-519

  Schubert, Ralf ^a,b   Reichenbach, J ^a   Zielen, S ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Ataxia telangiectasia (AT); Body mass index (BMI); IGF I; IGFBP 3

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BODY GROWTH; BODY MASS; CHEMOLUMINESCENCE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GROWTH FACTOR DEFICIENCY; GROWTH RETARDATION; HUMAN; IMMUNOASSAY; MALE; NUTRITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY;

ADOLESCENT; ADULT; AGE FACTORS; ATAXIA TELANGIECTASIA; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; NUTRITIONAL STATUS; SEX FACTORS;

EID: 20444492917     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02782.x     Document Type: Article

References (10)

1. Yang DQ, Kastan MB. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2000; 2:893-8.
2. Barlow C, Hirotsune S, Paylor R et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996; 86:159-71.
3. Peretz S, Jensen R, Baserga R, Glazer PM. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc Natl Acad Sci USA 2001; 98:1676-81.
4. Strasburger CJ, Bidlingmaier M, Wu Z, Morrison KM. Normal values of insulin-like growth factor I and their clinical utility in adults. Horm Res 2001; 55:100-5.
5. Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Perzentile für den Body-mass-index für das kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben Monatsschr. Kinderheilkd 2001; 149:807-18.
6. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding Protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363:1346-53.
7. Geenen V. The thymic insulin-like growth factor axis: involvement in physiology and disease. Horm Metab Res 2003; 35:656-63.
8. Busiguina S, Fer andez AM, Barrios V, Clark R, Tolbert DL, Berciano J, Torres-Aleman I. Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis 2000; 7:657-65.
9. Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regulation 1994; 4:11-9.
10. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protain-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004 Apr 24; 363 (9418):1346-53.